Last Updated on June 21, 2025 by The Health Master
Drug alert
Drug alert: Download the list of NSQ samples for April 2025, the link is given below: 196 drug samples declared as not of standard quality (NSQ), nationwide.
NSQ Lists are given below the article
Out of these 196 samples, 60 were declared NSQ by CDSCO and 136 were declared NSQ by various STATES across India.
Details of the NSQ samples declared by STATES is as under:
| Sr. | Name of STATES | Number of NSQ samples declared |
| 1 | Tamil Nadu | 38 |
| 2 | Punjab | 21 |
| 3 | Maharashtra | 19 |
| 4 | Kerala | 18 |
| 5 | Karnataka | 12 |
| 6 | Telangana | 12 |
| 7 | Puducherry | 8 |
| 8 | Himachal Pradesh | 3 |
| 9 | Tripura | 2 |
| 10 | J&K | 2 |
| 11 | Delhi | 1 |
| Total | 136 |
Drug alert: Previous months
March 2025: 131 drug samples declared as NSQ, out of these 131 samples, 70 were declared NSQ by CDSCO and 61 were declared NSQ by various STATES across India.
February 2025: 103 drug samples declared as NSQ, out of these 103 samples, 47 were declared NSQ by CDSCO and 56 were declared NSQ by various STATES across India.
January 2025: 145 drug samples declared as NSQ, out of these 145 samples, 52 were declared NSQ by CDSCO and 93 were declared NSQ by various STATES across India.
December 2024: 135 drug samples declared as NSQ, out of these 135 samples, 51 were declared NSQ by CDSCO and 84 were declared NSQ by various STATES across India.
November 2024: 111 drug samples declared as NSQ, out of these 111 samples, 41 were declared NSQ by CDSCO and 70 were declared NSQ by various STATES across India.
October 2024: 90 drug samples declared as NSQ, out of these 90 samples, 56 were declared NSQ by CDSCO and 34 were declared NSQ by various STATES across India.
September 2024: 67 drug samples declared as NSQ, out of these 67 samples, 49 were declared NSQ by CDSCO and 18 were declared NSQ by various STATES across India.
August 2024: 59 drug samples declared as NSQ, out of these 59 samples, 48 were declared NSQ by CDSCO and 11 were declared NSQ by various STATES across India.
July 2024: 70 drug samples declared as NSQ, out of these 70 samples, 57 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.
June 2024: 61 drug samples declared as NSQ, out of these 61 samples, 31 were declared NSQ by CDSCO and 30 were declared NSQ by various STATES across India.
May 2024: 52 drug samples declared as NSQ, out of these 52 samples, 39 were declared NSQ by CDSCO and 13 were declared NSQ by various STATES across India.
April 2024: 50 drug samples declared as NSQ, out of these 50 samples, 33 were declared NSQ by CDSCO and 17 were declared NSQ by various STATES across India.
The samples were withdrawn by the officers of CDSCO and State FDAs, and tested in the drug testing laboratories, i.e CDLs, CDTLs, and RDTLs, in Kolkata, Mumbai, Hyderabad, Chandigarh, Indore, Guwahati and State Govt Drug Testing Laboratories.
Drug alert: 131 drug samples declared as NSQ in March 2025
Drug alert: 103 drug samples declared as NSQ in February 2025
Drug alert: 135 drug samples declared as NSQ in December 2024
Drug alert: 111 drug samples declared as NSQ in November 2024
Drug alert: 90 drug samples declared as NSQ in October 2024
Drug alert: 67 drug samples declared as NSQ in September 2024
Drug alert: 59 drug samples declared as NSQ in August 2024
Drug alert: 70 drug samples declared as NSQ in July 2024
Drug alert: 61 drug samples declared as NSQ in June 2024
Drug alert: 52 drug samples declared as NSQ in May 2024
Drug alert: 50 drug samples declared as NSQ in April 2024
Drug alert: 66 out of 931 samples declared as NSQ in March 2024
Trending
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Commercial Testing Laboratories
Latest Notifications: Testing Laboratories
Commercial Testing Laboratories
Commercial Testing Laboratories: Procedure
Updated list of Medical Device Testing Laboratories (MDTLs)
List of Laboratory Instruments for Pharma & Cosmetics Industry
Calibration of Laboratory Instruments
NABL: List of NABL Accredited Testing Laboratories
NABL 164 released : Guidelines for Inter-laboratory comparison
NABL releases NABL 136: specific criteria for X-Ray equipment
NABL 126: Specific criteria for calibration of Medical Devices
Laboratory Waste Management, Types and Its Disposal
NABL certification procedure for Laboratories
Quality Assurance Vs Quality Control in the Pharma Industry
NABL certification for Laboratories: Let’s understand
Major FDA audit findings about Equipment and Instruments
Equipment and Instruments: Maintenance, difference and importance in the Pharma Industry
Upcoming events: Pharma, Cosmetics, Homoeopathy & Medical Devices
Cosmetics Testing in India: A Comprehensive Guide
Difference between Validation and Calibration in the Pharma Industry
Calibration of Laboratory Instruments
Difference: Disintegration and Dissolution test in pharma industry
Understanding DQ, IQ, PQ, and OQ in the Pharma Industry
Duties and responsibilities of QA person in Pharma Industry
Dissolution test: Importance in Pharma Industry
Licensing procedure for manufacturing of Drugs
Procedure to obtain license for manufacturing of Cosmetics
Procedure to obtain license for manufacturing of Homoeopathic Medicines
Procedure to obtain license for manufacturing of Medical Devices
Procedure to obtain License to Manufacture drugs for testing and analysis purposes
Procedure to obtain license for Blood Centre (Blood Bank)
Procedure to obtain license for Commercial Testing Laboratories
NPPA revised Ceiling price of 748 scheduled formulations: March 2025
Key Notes on Revised Schedule M: API Part-2
New prices of Coronary Stents in India effective from April 2025
New Boilers Bill 2024: A Safety Net for Pharma Industry
CDSCO: Apply online for Schedule M Extension by May 2025
USFDA inspection: At Alembic with zero observations
Karnataka streamlines Essential Narcotic Drugs
Tentative USFDA approval granted for Amifampridine Tablets
List of Drugs declared as NSQ by CDSCO for the Month of April– 2025.
NOT OF STANDARD QUALITY (NSQ) ALERT FOR THE MONTH OF APRIL-2025- (CDSCO/Central Laboratories)
As part of the continuous regulatory surveillance, drug samples are picked from sales/distribution point, analyzed and list of Not of Standard Quality (NSQ) drugs are displayed on CDSCO portal on monthly basis. The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market.
| S. No | Product/Drug Name | Batch No. | Manufacturing Date | Expiry Date | Manufactured By | NSQ Result | Reported by CDSCO Laboratory |
| 1. | Carboxymethyl Cellulose Sodium Eye Drops IP | MO24H27 | 08/2024 | 07/2026 | M/s. Martin & Brown Bio- sciences Pvt. Ltd. K.no. 918/419 Malkumajra Nalagarh Road Baddi, Dist. Solan (H.P.)-173205 | pH, Sterility and Assay | CDL, Kolkata |
| 2. | Carboxymethyl Cellulose Sodium Eye Drops IP | MO24H21 | 08/2024 | 07/2026 | M/s. Martin & Brown Bio- sciences Pvt. Ltd. K.no. 918/419 Malkumajra Nalagarh Road Baddi, Dist. Solan (H.P.)-173205 | pH, Sterility and Assay | CDL, Kolkata |
| 3. | Carboxymethyl Cellulose Sodium Eye Drops IP | MO24H22 | 08/2024 | 07/2026 | M/s. Martin & Brown Bio- sciences Pvt. Ltd. K.no. 918/419 Malkumajra Nalagarh Road Baddi, Dist. Solan (H.P.)-173205 | pH, Sterility and Assay | CDL, Kolkata |
| 4. | Bupivacaine Hydrochloride Injection IP (Bupicain-0.5%) | BPC24007 | 12/2024 | 10/2026 | M/s. Themis Medicare Limited, Sector 6A, Plot No.16,17,&18, IIE, SIDCUL Haridwar – 249403, Uttarakhand | Particulate matter and Description | CDL, Kolkata |
| 5. | Ceftriaxone and Sulbactam for Injection IP (CEFRITZ S 1.5) | 24DH13V | 08/2024 | 07/2026 | M/s. MMG Healthcare, Trilokpur Road, Kala Amb, Distt. Sirmour- 173030 (H.P.) | Bacterial endotoxins for Sterile water for Injection. | CDL, Kolkata |
| 6. | Pantoprazole Gastro- Resistant Tablets IP 40 mg. | MT240578 | 08/2024 | 07/2026 | M/s. Mancare Laboratories Pvt. Ltd., Plot No-11, Pharmacity, Selaqui, Dehradun, Uttarkhand-248011 | Dissolution in Buffer Stage | CDL, Kolkata |
| 7. | Oxcarbazepine Tablets IP 300 mg (OXCARBAJAJ 300) | OXB02I24 | 09/2024 | 08/2026 | M/s. Bajaj Healthcare Ltd. R.S. No. 1818, Manjusar-Savli Road, At & Post Manjusar, Tal Savli, Dist. Vadodara-391775, Gujarat, India | Dissolution | CDL, Kolkata |
| 8. | Calcium & Vitamin D3 Tablets IP | QT23136 | 11/2024 | 10/2026 | M/s. Quest Laboratories Limited, Plot No.-45, Sector-III, Pithampur, Dist-Dhar-454775 (M. P.) | Dissolution (for Calcium) and Assay of Elemental Calcium | CDL, Kolkata |
| 9. | Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1289 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 10. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1292 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 11. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1286 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 12. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1298 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 13. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1301 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 14. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1302 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 15. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1303 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 16. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1304 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 17. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1305 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 18. | Calcium Carbonate 500 mg +VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1306 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod 389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 19. | Amikacin Sulphate Injection I.P. 500 mg | 24AM18 | 10/2024 | 09/2026 | M/s. SAI Parenterals Limited, D1 &D4, Survey No.280, Phase-V, IDA, Jeedimetla, Hyderabad- 500055.Telangana, India | Particulate matter and Description | CDL, Kolkata |
| 20. | Sucralfate & Oxetacaine Suspension (Rabeflux Suspension) | RBLS-02501 | 01/2025 | 12/2026 | M/s. Tidal Laboratories Pvt. Ltd., Patch-5, Phase-II, Gowalthai, Distt. Bilaspur- 174201 (H.P.), INDIA | Identification, Assay of Sucralfate and Assay of Oxetacaine | CDL, Kolkata |
| 21. | Iron Sucrose Injection USP 100mg/5ml | 24RS15 | 12/2024 | 11/2026 | M/s. SAI Parenterals Limited, D1 &D4, Survey No.280, Phase-V, IDA, Jeedimetla, Hyderabad-500055, TS | pH and Alkalinity | CDL, Kolkata |
| 22. | Iron Sucrose Injection USP 100mg/5ml | 24RS03 | 01/2024 | 12/2025 | M/s. SAI Parenterals Limited, D1 &D4, Survey No.280, Phase-V, IDA, Jeedimetla, Hyderabad-500055, TS | pH | CDL, Kolkata |
| 23. | Iron Sucrose Injection USP 100 mg/5ml | 24RS06 | 02/2024 | 01/2026 | M/s. SAI Parenterals Limited, D1 &D4, Survey No. 280, Phase-V, IDA, Jeedimetla, Hyderabad-500055, TS | pH and Alkalinity | CDL, Kolkata |
| 24. | Compound Sodium Lactate Injection IP (RINGER-LACTATE SOLUTION FOR INJECTION ) (RL) | 1I245476 | 09/2024 | 08/2027 | M/s. Aculife Healthcare Pvt. Ltd., Sachana, Gujarat- 382150, India | Sterility | CDL, Kolkata |
| 25. | Rifampicin, Isoniazid and Ethmbutol Hydrochloride Tablets IP | TR-820008 | 07/2024 | 06/2026 | M/s. Centurion Remedies Pvt. Ltd., G/5,6, B.I.D.C. Gorwa, Vadodara -390016 | Assay of Rifampicin | CDL, Kolkata |
| 26. | Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1294 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod-389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 27. | Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1299 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod-389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 28. | Calcium Carbonate 500 mg + VIT. D3 250 IU Tablets IP (CALXIA 500 ) | GTL1300 | 12/2024 | 11/2026 | M/s. Gidsha Pharmaceuticals, Plot No. 611 612, Mega GIDC, Kharedi, Dahod-389151, Gujarat. | Dissolution (for Calcium) | CDL, Kolkata |
| 29. | Ondansetron Oral Solution I.P. 2mg/5ml | ONES-1004 | 09/2024 | 08/2026 | M/s. Wings Biotech, 43 and 44, HPSIDC, Industrial Area, Baddi-173 205 (H.P.) | Related Susbtances | CDL, Kolkata |
| 30. | Gentamicin Injection IP (Gentatore Injection 80 mg/2ml) | IGMG418 | 07/2024 | 06/2026 | M/s. Regain Laboratories, 134/5, HTM Road, Rajpur Lane, Hisar-125001, Haryana | Particulate matter and Description | CDL, Kolkata |
| 31. | Teneligliptin & Metformin Hydrochloride (Sustained Release) Tablets IP (Teglisure-M 500) | AOT244-00B | 03/2024 | 02/2026 | M/s. Astonea Labs Pvt. Ltd., Vill- Haripur, Teh. Raipur Rani, Dist. Panchkula, Haryana, INDIA-134204 | Assay/content of Teneligliptin | CDL, Kolkata |
| 32. | Cefpodoxime Proxetil Tablets I.P. 200 mg (BREPOD-200) | ST-25456 | 10/2024 | 09/2026 | M/s. Sunvij Drugs Private Limited, 511, GIDC, Waghodia, Baroda-391760, Gujarat | Dissolution | CDL, Kolkata |
| 33. | Rabeprazole Sodium Injection IP | MD23H19 | 08/2023 | 07/2025 | M/s. Martin & Brown Bio Sciences, K. No. 918/419, Malkumajra, Nalagarh Road, Baddi, Dist. Solan (H.P.)- 173205 | pH, Particulate matter, Clarity of Solution, Assay of Rabeprazole Sodium and Description | CDL, Kolkata |
| 34. | Nimesulide & Paracetamol Tablets (Somu Gold) | TTX0093 | 01/2024 | 12/2026 | M/s.Pro-pharma Care Pvt. Ltd., Khasara No. : 68, 69, 71, Village : Sikandarpur, Bhaiswal, Near Bhagwanpur, Roorkee, Distt. Haridwar, Uttarakhand-247661 | Dissolution | RDTL, Guwahati |
| 35. | Fluconazole Tablets I.P. 150 mg (Megmazole- 150 Tablets) | TSF-C0116 | 01/2024 | 12/2025 | M/s.Spen Formulations Pvt. Ltd., Plot No-123, Industrial Area, Mehatpur, Distt. UNA174315 (H.P.) | Assay/Content of Fluconazole | RDTL, Guwahati |
| 36. | Ampicillin Sodium Injection I.P. (AMPIVEE- 500 Injection) | TGDI082319 04 | 8/2023 | 07/2025 | M/s.T & G Medicare, Village Kunjahal, PO Baddi, Distt:. Solan (H.P.) | Sterillity | RDTL, Guwahati |
| 37. | Sulbactam Sodium Sterile I.P./USP. | 23051901 | 5/2023 | 04/2026 | M/s.Reyoung Pharmaceutical Co. Ltd., No.1,Ruiyang Road, Yiyuan Country,Shandong Province,P.R.China,Post Code:256100.Imported By: Shah TC Distribution LLP,Gala No.2 & 3, 1st Floor, BLD No. B1.H.No.709/2&709/3,Radha Krushna Compound,T.M. Industrial Park, Pimplas Bhiwandi,MH-421302, India. | “Identification and Assay/Content of Sulbactam Sodium | RDTL, Guwahati |
| 38. | Sulbactam Sodium Sterile I.P./USP. | 23051806 | 5/2023 | 04/2026 | M/s.Reyoung Pharmaceutical Co. Ltd., No.1,Ruiyang Road, Yiyuan Country,Shandong Province,P.R.China,Post Code:256100.Imported By: Shah TC Distribution LLP,Gala No.2 & 3, 1st Floor, BLD No. | Identification and Assay/Content of Sulbactam Sodium | RDTL, Guwahati |
| B1.H.No.709/2&709/3,Radha Krushna Compound,T.M. Industrial Park, Pimplas Bhiwandi,MH-421302, India. | |||||||
| 39. | Sulbactam Sodium Sterile I.P./USP. | 23051903 | 5/2023 | 04/2026 | M/s.Reyoung Pharmaceutical Co. Ltd., No.1,Ruiyang Road, Yiyuan Country,Shandong Province,P.R.China,Post Code:256100.Imported By: Shah TC Distribution LLP,Gala No.2 & 3, 1st Floor, BLD No. B1.H.No.709/2&709/3,Radha Krushna Compound,T.M. Industrial Park, Pimplas Bhiwandi,MH-421302, India. | Identification and Assay/Content of Sulbactam Sodium | RDTL, Guwahati |
| 40. | Ciprofloxacin Tablets IP 250 mg (Ciprodac 250) | CT24001 | 2/2024 | 01/2027 | M/s.CADILA PHARMACEUTICALS LIMITED, 1389, Dholka- 382225, Dist. Ahmedabad | Dissolution” of Ciprofloxacin | RDTL, Guwahati |
| 41. | Ciprofloxacin Tablets IP 250 mg | CITB-02 | 7/2024 | 06/2026 | M/s. NESTOR PHARMACEUTICALS LIMITED, 11, Western Extension Area, Faridabad – 121 001, INDIA | Dissolution | RDTL, Guwahati |
| 42. | Sulbactam Sodium Sterile I.P./USP | 23051904 | 5/2023 | 04/2026 | M/s.Reyoung Pharmaceutical Co. Ltd., No.1,Ruiyang Road, Yiyuan Country,Shandong Province,P.R.China,Post Code:256100.Imported By: Shah TC Distribution LLP,Gala No.2 & 3, 1st Floor, BLD No. B1.H.No.709/2&709/3,Radha Krushna Compound,T.M. Industrial Park, Pimplas Bhiwandi,MH-421302, India. | Identification and Assay/Content of Sulbactam Sodium | RDTL, Guwahati |
| 43. | Sulbactam Sodium Sterile I.P./USP. | 23051902 | 5/2023 | 04/2026 | M/s.Reyoung Pharmaceutical Co. Ltd., No.1,Ruiyang Road, Yiyuan Country,Shandong Province,P.R.China,Post Code:256100.Imported By: Shah TC Distribution LLP,Gala No.2 & 3, 1st Floor, BLD No. B1.H.No.709/2&709/3,Radha Krushna Compound,T.M. Industrial Park, Pimplas Bhiwandi,MH-421302, India. | Identification and Assay/Content of Sulbactam Sodium | RDTL, Guwahati |
| 44. | Albendazole Tablets IP 400 mg | LMT241100 | 9/2024 | 08/2026 | M/s.Life Max Cancer Laboratories, Plot No. 106 & 106 A, Sector6A, IIE, SIDCUL, Haridwar249403 (U.K) | Dissolution | RDTL, Guwahati |
| 45. | Telmisartan I.P. 40 mg, Amlodipine Besylate I.P. 5 mg Tablets | ST 211 | 4/2024 | 03/2026 | M/s.Soham Healhcare INC, Soham Healthcare Inc A-49, Sector-25, Gandhinagar, Gujarat | “Dissolution” (Telmisartan and Amlodipine) and “Assay/ content of Telmisartan and Amlodipine” | CDTL-Mumbai |
| 46. | Pioglitazone Hydrochloride Tablets (GLITO 15) | D40292 | 5/2024 | 04/2027 | M/s.Medley Pharmaceuticals Ltd., Plot No. 18 & 19, Survey No.378/7 & 8, 379/2 & 3, Zari Causeway Road, Kachigam Daman- 396210 (U.T), INDIA | “Dissolution” | CDTL-Mumbai |
| 47. | Glimepiride Tablets I.P. 1 mg | 12801124 | 8/2024 | 07/2026 | M/s.Karnataka Antibiotics & Pharmaceuticals Limited (A Govt of India Enterprise), Plot No.14, II Phase, Peenya, Bengaluru – 560 058. | “Related substances” | CDTL-Mumbai |
| 48. | Telmisartan & Hydrochlorothiazide Tablets IP (Telmijack-H) | T-20560 | 3/2024 | 02/2026 | M/s.Jackson Laboratories Pvt. Ltd., Plot No. 56 & 61, Industrial Area, Phase III, Sansarpur Terrace, Distt. Kangra (H.P.)- 176501. | “Related substances and Assay of Hydrochlorothiazi de” | CDTL-Mumbai |
| 49. | Sulphamethoxazole and Trimethoprim Tablets IP | MT386 | 10/2023 | 09/2026 | M/s.Mayasha Lifesciences, H.B. 86, Village-Bhatian Nalagarh, Distt.-Solan (H.P.) 174101 | Dissolution of Sulphamethoxazol e | RDTL, Chandigarh |
| 50. | Levamisole & Oxyclozanide Bolus Vet. (Wormizole Bolus) | EMVB-24162 | 10/2024 | 09/2026 | M/s.Events Corporation, UNIT- II, Kala Amb, Tehsil Nahan, District Sirmour (H.P.)-173030 | Disintegration test | RDTL, Chandigarh |
| 51. | Sodium Chloride Injection IP 0.9 %w/v | LV4979 | 11/2024 | 10/2026 | M/s.Captab Biotec, Unit-II, Plot No.125, E.P.I.P. Road, Mauja, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Bacterial endotoxins and Sterility | RDTL, Chandigarh |
| 52. | Sodium Chloride Injection IP 0.9 %w/v | LV4987 | 11/2024 | 10/2026 | M/s.Captab Biotec, Unit-II, Plot No.125, E.P.I.P. Road, Mauja, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Bacterial endotoxins and Sterility | RDTL, Chandigarh |
| 53. | Sodium Chloride Injection IP 0.9 %w/v | LV4983 | 11/2024 | 10/2026 | M/s.Captab Biotec, Unit-II, Plot No.125, E.P.I.P. Road, Mauja, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Bacterial endotoxins and Sterility | RDTL, Chandigarh |
| 54. | Sodium Chloride Injection IP 0.9 %w/v | LV4984 | 11/2024 | 10/2026 | M/s.Captab Biotec, Unit-II, Plot No.125, E.P.I.P. Road, Mauja, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Bacterial endotoxins and Sterility | RDTL, Chandigarh |
| 55. | Sodium Chloride Injection IP 0.9 %w/v | LV4985 | 11/2024 | 10/2026 | M/s.Captab Biotec, Unit-II, Plot No.125, E.P.I.P. Road, Mauja, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Bacterial endotoxins and Sterility | RDTL, Chandigarh |
| 56. | Sodium Chloride Injection IP 0.9 %w/v | LV4982 | 11/2024 | 10/2026 | M/s.Captab Biotec, Unit-II, Plot No.125, E.P.I.P. Road, Mauja, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Bacterial endotoxins and Sterility | RDTL, Chandigarh |
| 57. | Sodium Chloride Injection IP 0.9 %w/v | LV4978 | 11/2024 | 10/2026 | M/s.Captab Biotec, Unit-II, Plot No.125, E.P.I.P. Road, Mauja, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Bacterial endotoxins and Sterility | RDTL, Chandigarh |
| 58. | Sodium Chloride Injection IP 0.9 %w/v | LV4988 | 11/2024 | 10/2026 | M/s.Captab Biotec, Unit-II, Plot No.125, E.P.I.P. Road, Mauja, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Particulate matter, Bacterial endotoxins and Sterility | RDTL, Chandigarh |
| 59. | Doxycycline Capsules IP 100 mg | B240705 | 05/2024 | 04/2026 | M/s.Bochem Healthcare Pvt. Ltd., 83-84, Industrial Area, Dewas Road, Nagziri, Ujjain 45601-(M.P.) India | Dissolution of Doxycycline | RDTL, Chandigarh |
| 60. | Levetiracetam Tablets IP 500 mg | LMT241488 | 12/2024 | 11/2026 | M/s.Life Max Cancer Laboratories Plot No. 106 & 106A, Sector-6A, IIE, SIDCUL, Haridwar-249403 (U.K) | Dissolution | CDTL, Indore |
Not of Standard Quality (NSQ) drugs:
The drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs.
(Further, the term ‘standards of quality’ is defined under the Section 16 (1) (a) of Drugs & Cosmetics Act, 1940, that the ‘standards of quality’ mean that the drug complies with the standards set out in the Second Schedule of the said Act.)
List of Drugs declared as NSQ by STATES for the Month of April– 2025.
NOT OF STANDARD QUALITY ALERT FOR THE MONTH OF APRIL– 2025 – (State Laboratories)
As part of the continuous regulatory surveillance, Drugs /Cosmetics/Medical Devices samples are picked from sales/distribution point, analyzed and list of Not of Standard Quality (NSQ) drugs are displayed on CDSCO portal on monthly basis. The purpose of displaying the NSQ list is to make stakeholders aware about the NSQ batches identified in the market.
| S. No | Product/Drug Name | Batch No. | Manufactu ring Date | Expiry Date | Manufactured By | NSQ Result | Reported by State Laboratory |
| 1. | Nimesulide & Paracetamol Bolus (Vet.) (Nip-UP Bolus) | NPB-23221 | Feb-24 | Jan-26 | M/s. Akme Biotec, Plot No. 24, Sector-5, I.I.E., Sidcul, Haridwar (U.K.) | Disintegration Test | Karnataka |
| 2. | WORMKILL-PLUS (Albendazole & Ivermectin Oral Suspension) | SRVL-24003 | Jun-24 | May-26 | M/s. SPAS Remedies, Vill- Bersan, P.O-Lodhi Majra, Tehsil- Baddi Distt. Solan (H.P) 173205 | Assay for Albendazole and Ivermectin | Karnataka |
| 3. | Paracetamol Tablets IP 650 mg | PCT24034 | Feb-24 | Jan-26 | M/s. Vivek Pharmachem (India) Ltd., NH-8, Chimanpura, Amer, Jaipur-303102 | Test for Dissolution” and “Description | Karnataka |
| 4. | Glimepiride 1 mg & Metformin HCl 500mg (Sustained Release) Tablets IP | SPT40298 | Sep-24 | Aug-26 | M/s. Surge Pharmaceuticals Pvt. Ltd., Plot No. C-78 & 79, Additional M.I.D.C., Jejuri- 412303, Taluka Purandhar District, Pune, Maharashtra, India | Test for Dissolution” and “Assay for Glimeperide | Karnataka |
| 5. | Spoorthi Aloegramflour Soap | 6 | Jun-24 | May-27 | M/s. Spoorthi Herbals No.:299, SH1 Kalakupi, Airport Road, Belagavi, Karnataka-591121 | Test for Matter insoluble in Alcohol only | Karnataka |
| 6. | Acremox-500 (Amoxycillin Trihydrate & Lactic Acid Bacillus Capsules) | ABC24002 | Apr-24 | Mar-26 | M/s. Alexa Pharmaceuticals, Plot. No. 20, Ext, HPSIDC, Ind, Area, Baddi, Distt. Solan (H.P) 173205 | Assay for Amoxycillin | Karnataka |
| 7. | Ketoconazole Tablets I.P. 200mg | GT301737 | Mar-24 | Feb-26 | M/s. Gnosis Pharmaceuticals Pvt. Ltd., Nahan Road, Village Moginand, Kala-Amb, Distt. Sirmour (H.P)-173030 | Description only | Karnataka |
| 8. | Compound Sodium Lactate Injection I.P (Ringer Lactate Solution for injection I.P) (RL) | 4D40168 | Oct-24 | Sep-27 | M/s. IHL Lifesciences Pvt. Ltd., At village: Panwa, Tehsil: Kasrawad, Dist: Khargone 451228 (M.P) India | Test for Sterility | Karnataka |
| 9. | Amitriptyline HCl & Chlordiazepoxide Tablets USP (AMTOPIC-PLUS) | N2402062 | Feb-24 | Jan-26 | M/s. Talent Healthcare, 66-67, Sector-6A, Sidcul, Iie, Haridwar- 249403 (Uttarakhand) | Assay for Amitriptyline only | Karnataka |
| 10. | Sodium Chloride Injection IP (0.9% W/v) NS | 4HB01401 | May-24 | Apr-27 | M/s. Aishwarya Lifesciences, plot no 11, Ind. Area VPO-Lodhimajra, Baddi, Distt-Solan (H.P)-174101 (India) | Test for Sterility | Karnataka |
| 11. | Ofloxacin & Ornidazole Tablets IP (200 mg +500 mg) (Floxo OZ) | TAH-231704 | Sep-23 | Aug-25 | M/s. Prochem Pharmaceuticals Pvt. Ltd., 140-141, Makkanpur, Bhagawanpur, Roorkee, Dist. Haridwar (UK)-247661 | Description | Karnataka |
| 12. | Infusion Set (BMD) | BIV-020 | Aug-24 | Jul-27 | M/s. Bhgwati Medicare Devices, 8, Maruti Industrial Estste, Nr. Sindhvai Mata Temple, C.T.M- Ramol Road, Amraiwadi, Ahmedabad-380026. Gujarat (India) | Test for Sterility | Karnataka |
| 13. | Albendazole Tablet IP 400 mg, | T24/007A | Dec-24 | Nov-26 | M/s. Samkem 15-B & 10-B, A.K.V.N Industrial Area, Rangwasa, Rao, Indore – 453331, Madhya Predesh. | Dissolution does not comply as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 14. | Albendazole Tablet IP 400 mg, | T24/020A | Dec-24 | Nov-26 | M/s. Samkem 15-B & 10-B, A.K.V.N Industrial Area, Rangwasa, Rao, Indore – 453331, Madhya Predesh. | Dissolution does not comply as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 15. | Albendazole Tablet IP 400 mg, | T24/016A | Dec-24 | Nov-26 | M/s. Samkem 15-B & 10-B, A.K.V.N Industrial Area, Rangwasa, Rao, Indore – 453331, Madhya Predesh. | Dissolution does not comply as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 16. | Albendazole Tablets IP 400 mg | T24/011A | Dec-24 | Nov-26 | M/s. Samkem 15-B & 10- B,A.K.V.N.Industrial Area, Rangwasa, Rao,Indore- 453331.(M.P.)(WHO-GMP & GLP Certifled Company) (AN ISO 9001:2015 Certifled Company) MADHYA PRADESH | Sample Does not comply in respect of Dissolution Test as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 17. | Albendazole Tablet IP 400 mg, | T24/015A | Dec-24 | Nov-25 | M/s. Samkem15-B & 10-B, A.K.V.N. INDUSTRIAL AREA, RANGWASA RAO, INDORE – 453 331 (M.P.) MADHYA PRADESH | Dissolution does not comply as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 18. | Albendazole Tablets IP 400 mg | T24/018A | Dec-24 | Nov-26 | M/s. Samkem15-B & 10-B, A.K.V.N. INDUSTRIAL AREA, RANGWASA RAO, INDORE – 453 331 (M.P.) MADHYA PRADESH | Dissolution dose not complies as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 19. | Albendazole Tablet IP 400 mg, | C25F944019 | Jun-24 | May-26 | M/s. Concept Pharmaceuticals Ltdm Khasra No. 104, Asaf Nagar, Roorkee – 247 667. Uttarakhand. | Dissolution dose not complies as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 20. | Albendazole Tablet IP 400 mg, | C25F944019 | Jun-24 | May-26 | M/s. Concept Pharmaceuticals Ltdm Khasra No. 104, Asaf Nagar, Roorkee – 247 667. Uttarakhand. | Dissolution dose not complies as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 21. | Emiral OD Tablets, Ondansetron orally disintegrating Tablets IP | HT24565 | Jul-24 | Jun-26 | M/s Habitare Pharma Pvt Ltd Plot no. 43-44, Industrial Estate, HSIIDC, Alipur, Barwala, Distt- Panchakula (HR) – 134118 HARYANA | Disintegration dose not complies as per IP. | State Lab, Drugs Control Laboratory, Telangana. |
| 22. | Ambroxol Hydrochloride Syrup 30 mg/5 ml | 724559 | Dec-24 | Nov-26 | M/s.Syndicate Pharma 185/B, 185/B-1, 187/A & 188, Sector-F, Sanwer Road, Indore-452015 Madhya Pradesh | Misbranded The drug failed to indicate the common name of the colour, used in the drug, on the product label, as required under Rule 127(2) of the Drugs Rules, 1945. The label merely states Approved Colour Used. Hence, the drug is deemed to be Misbranded under Section 17 of the Drugs and Cosmetics Act, 1940, as it is not labeled in the prescribed manner. | State Lab, Drugs Control Laboratory, Telangana. |
| 23. | Lulimark Creams, Luliconazole Cream 1% | 92447 | Sep-24 | Aug-26 | M/s. Forever LifeScience Pvt.Ltd. 74/D, Sopan Kesar Industrial Hub, Moraiya, Dist. Ahmedabad – 382213 GUJARAT | Misbranded The drug Product Luliconazole Cream is official, i.e., it is included in the current edition of the Indian Pharamacopoeia (IP- 2022). As required under the Second Schedule of the Drugs and Cosmetics Act, 1940, the said drug Product shall mandatorily comply with the standards set out in the Indian Pharmacopoeia. However, the designation “IP”in conjunction with the official title Luliconazole Cream was not mentioned on the label of the drug product as an indication that it purports to comply with IP standards. Hence, drug under Section 17 of the Drugs and Cosmetics Act, 1940 as it is not labeled in the prescribed manner. | State Lab, Drugs Control Laboratory, Telangana. |
| 24. | Ambroxol Hydrochloride Syrup | 724543 | Nov-24 | Oct-26 | M/s By: Syndicate Pharma 185/B, 185/B-1, 187/A & 188, Sector-F, Sanwer Road, Indore – 452015 MADHYA PRADESH | Misbranded The drug failed to indicate the common name of the colour, used in the drug, on the product label, as required under Rule 127(2) of the Drugs Rules, 1945. The label merely states Approved Colour Used. Hence, the drug is deemed to be Misbranded under Section 17 of the Drugs and Cosmetics Act, 1940, as it is not labeled in the prescribed manner. | State Lab, Drugs Control Laboratory, Telangana. |
| 25. | Winocin 500 (Paracetamol tablets IP 500 mg) | JT-2405719 | May-24 | Oct-26 | M/s.Jineka Healthcare Pvt. Ltd, Plot No. 15, Sector- 6B, IIE, Ranipur, Haridwar (UK) 249403 | The sample does not conform to standard quality in respect of the test for “Dissolution” performed. | State Drugs Testing Laboratory, Agartala, Tripura. |
| 26. | Fevimed (Paracetamol tablets IP 500 mg) | T-23204 | Sep-23 | Aug-25 | M/s.Kshipra Drugs Pvt. Ltd. 40- 41/22B, Industrial Area No. 1, Dewas (MP) 455001. | The sample does not conform to standard quality in respect of the test for “Dissolution” performed. | State Drugs Testing Laboratory, Agartala, Tripura. |
| 27. | Sucrapolis-O Suspension | CSDL24368 | Oct-24 | Sep-26 | M/s.CSD Lifesciences, Village:Malkumajra, Morepen Road, Baddi, Distt, Solan (HP)- 173205 | sample does not conform to label claim with respect to the content of Oxetacaine | Drugs Testing Laboratory, Chennai – 6 |
| 28. | Gentamicin Injection I.P- 2ml | 24BUH83 | Aug-24 | Jul-26 | M/s.SVP Life Sciences, C/10-1, Sara Industrial Estate, Selequi, Dehradun. | Sample does not conform to the requirement for pH. | King Institute of Preventive Medicine & Research, Guindy, Chennai-32 |
| 29. | Gentamicin Injection I.P- 2ml | YGN4102 | Jul-24 | Jun-26 | M/s.Yeluri formulations Pvt Ltd, Sy.296/7/6, I.D.A Bollaram, Samgareddy, District-502 325. Telangana-India. | Sample does not conform to the requirement for pH. | King Institute of Preventive Medicine & Research, Guindy, Chennai-32 |
| 30. | Cefixime Tablets IP 400 mg | HTB404G | Jul-24 | Jun-26 | M/s.Himalaya Meditek Pvt Ltd, Plot No.35&36 Pharmacity, Selaqui Industrial Area, Dehradun – 248 197 | Sample does not conform to IP Specification for Cefixime Tablets with respect to the content of Anhydrous Cefixime in Cefixime Trihydrate. | Drugs Testing Laboratory, Madurai-19 |
| 31. | L-Histact-M Tablets | 24DT122A | Jun-26 | May-27 | M/s.Kashmik Formuation Pvt Ltd, PF-13, Opp procter & Gamble, Bol GIDC-2, Sanand, Ahmedabad – 382 170, Gurarat, India | Sample does not conform to IP Specification for Levocetrizine Hydrocloride and Montelukast Tablets with respect to the contect of Levocetrizine Hydrochloride and Montelukast in Montelukast in Montelukast sodium. | Drugs Testing Laboratory, Madurai-19 |
| 32. | Kelan Soap(Ketoconazole Meidcated Soap) | 8091 | Oct-26 | Sep-26 | M/s.Vimson Derma, 816/3, Kothari Estate, Santej-382 721 (Gujarat) | sample does not conform to label claim with respect to the content of Ketoconazole | Drugs Testing Laboratory, Madurai-19 |
| 33. | Cefixime & Potassium Clavulanate Tablets (Alfix-CV) | CT24117D | Aug-24 | Jan-26 | M/s.Curehealth Pharmaceticals Pvt Ltd, Vill Ranupur, P.O Deothi , Tehsil & District Solan (HP) 173211 | Sample does not conform to label claim with respect to the content of Clavulanic Acid in Potassium Clavulanate. | Drugs Testing Laboratory, Madurai-19 |
| 34. | Lelet-M Syrup (Montelukast Sodium and levocetirizine hydrochloride syrup) | LLMS-063 | Apr-24 | Mar-26 | M/s.IOSIS Remedies pvt ltd, Rajpura road, village-khera nihla, Tehsil-Nalagarh, District-solan. Himachal Pradesh – 174 101 India | sample does not conform to label claim with respect to content of Montelukast in Montelukast sodium | Drugs Testing Laboratory, Madurai-19 |
| 35. | Amoxycillin and potassium clavulanate tablets IP (AUGMONT CV 625 DUP Co- amoxiclav) | BT408244A | Aug-24 | Apr-26 | M/s.Nikvin Healthcare (I) Pvt Ltd, Baddi-Barotiwala Road, Behind Govt, Toimber Depot Vill, Katha. Baddi(HP)-173 205 | Sample does not conform to IP specification for amoxycillin and potassium clavulanate tablets with respect to the content of Clavulanic acid in potassium clavulanate. | Drugs Testing Laboratory, Madurai-19 |
| 36. | Amoxycillin and potassium clavulanate tablets IP 625 mg | BT240491 | May-24 | Apr-26 | M/s.Hindustan Antibiotics Ltd, at: Village Saini Majra, Tehsil Nalagarh Dist. Solan (HP) – 174 101 | Sample does not conform to IP specification for amoxycillin and potassium clavulanate tablets with respect to the content of Clavulanic acid in potassium clavulanate. | Drugs Testing Laboratory, Madurai-19 |
| 37. | Lidocaine Hydrochloride and Gabapentin Gel (Gabaneuron Gel) | PWBBO7 | Jun-24 | Nov-25 | M/s.Pure & Cure Healthcare Pvt Ltd,(A Subsidiary of Akums Drugs & Pharmaceuticals Ltd) Plot No. 26A, 27-30,Sectir-8A, I.I.E, SIDCUL, Raniput, Haridwar-249 403, Uttarakhand | Sample does not conform to lebel claim with respect to the content of Gabapentin | Drugs Testing Laboratory, Madurai-19 |
| 38. | Petben (Benzoyl peroxide shampoo 2.5%) | 0000678585 | Mar-24 | Feb-26 | M/s.Hidustan Antibitics Ltd, at Village Saini Majra, Tehsil Nalagarh Dist. Solan (HP) – 174 101 | Sample does not conform to lebel claim with respect to description of shampoo | Drugs Testing Laboratory, Madurai-19 |
| 39. | Omeprazole Capsules IP 20mg | HCN423F | Jun-24 | May-26 | M/s.Himalaya Meditek Pvt Ltd, Plot No.35&36 Pharmacity, Selaqui Industrial Area, Dehradun – 248 197 | Sample does not conform to IP specification with respect to Uniformity of weight | Drugs Testing Laboratory, Madurai-19 |
| 40. | Clotrimazole and Selenium Sulfide Suspension, candid tv | 46230305 | Dec-23 | Nov-25 | M/s.Glenmark Pharmaceuticals Ltd, At, Plot No. 38939 Sector-II, I.I.E, Sidcul, Haridwar, Uttarakhand-249 403. | Sample does not conform to label claim with respect to identification and the content of clotrimazole (Deemed to be spurious) | Drugs Testing Laboratory, Madurai-19 |
| 41. | Bisacodyl Tablets Ip 5mg | TA24366 | Jun-42 | Apr-26 | M/s. Saintlife Pharmaceuticals Ltd, 323, Central Hope Town, Industrial Area, Selaqui, Dehradun-248011, Uttarakhand. | Sample does not conform to IP specification for Bisacodyl Tablets with respect to Dissolution | Drugs Testing Laboratory, Chennai-06 |
| 42. | Amoxycillin & Potassium Calvulanate Tablets | BT406210A | Jun-24 | May-26 | M/s.Nikvin Healthcare (I) Pvt Ltd, Baddi-Barotiwala Road, Behind Govt, Toimber Depot Vill, Katha. Baddi(HP)-173 205 | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Dissolution for Clavulanic Acid and to the content of Clavulanic Acid in Potassium Clavulanate Diluted | Drugs Testing Laboratory, Chennai-06 |
| 43. | Nitrobi-CR 2.6(Nitroglycerin Controlled Release Tablets 2.6mg) | JT-2312229 | Dec-23 | Nov-25 | M/s.Jeneka Healthcaere Pvt Ltd, Khasra No.507-525, Bedpur Crossing Bhagwanpur By Pass, Roorkee, Distt, Haridwar, Uttarakhand. | Sample does not conform to Label Claim with respect to the content of Nitroglycerine in Diluted | Drugs Testing Laboratory, Madurai-19 |
| 44. | Bisacodyl Tablets IP 5mg | TA24688 | Aug-24 | Jul-26 | M/s.Saintlife Pharmaceuticals Ltd, 323, Central Hope Town, Industrial Area, Selaqui, Dehradun-248011, Uttarakhand. | Sample does not conform to IP specification for Bisacodyl Tablets with respect to Dissolution (Acid medium and Buffer medium) | Drugs Testing Laboratory, Chennai-06 |
| 45. | Moxivin-CV 625 (Amoxycillin and Potassium Calvulnate Tablets IP) | VMIT2404 | Oct-24 | Sep-26 | M/s.Vertex Pharma Chemicals, Plot No.60-A,61-A, PIPDIC Electronic Park, Thirubhuvanai, Puducherry-605107 | The Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Identification of Potassium Clavulanate, Uniformity of weight and content of Amoxycillin in Amoxycillin Trihydrate and Clavulanic Acid in Potassium Clavulanate (Deemed to be spurious). | Drugs Testing Laboratory, Madurai-19 |
| 46. | Burmoxicla+V(Amoxycill in & Potassium Clavulanate Oral Suspension IP) | ABD-187C | Jun-24 | Nov-25 | M/s.Azot Life Sciences, Vill.Chewa, P.O, Kumarhatti, Distt. Solan – 173229(H.P) | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate oral suspension with respect to the content of Clavulanic Acid in Potassium Clavulanate | Drugs Testing Laboratory, Madurai-19 |
| 47. | Z&D Syrup (Zinc Gluconate Oral Solution 20mg) | XSZE24005 | Aug-24 | Jan-26 | M/s.Hema Laboratories Pvt Ltd, Plot No.29, Pharma City, Selaqui Industrial, Area, Dehradun – 248011, Uttarakhand. | Sample does not conform to Label Claim with respect to content of Elemental Zinc in Zinc Gluconate | Drugs Testing Laboratory, Madurai-19 |
| 48. | Softuss-D (Dextromethorphan Hydrobromide, Phenylephrine Hydrochloride & Chlorpheniramine Maleate Syrup) | DL2501013B | Jan-25 | Dec-26 | M/s.Indorama Health Care Pvt Ltd, 204-205, HSIIDC, Manakpur, Industrial Area, Jagadhri, Distt, Yamuna Nagar (Haryana), 135003 | Sample does not conform to IP specification for label claim with respect to the content of Phenylephrine Hydrochloride | Drugs Testing Laboratory, Chennai-06 |
| 49. | Chlorpheniramine Maleate IP & Noscapine IP Oral Syrup (Coscopin Linctus) | VTL4006 | Mar-24 | Feb-26 | M/s.Biological E Limited, Plot 47B/2, Street No.04, Phase-1, IDA Cherlapally Village, Kapra Mandal, Medchal-Malkajgiri District-500052, Telangana State, India. | Sample does not conform to Label claim with respect to the content of Noscapine | Drugs Testing Laboratory, Madurai-19 |
| 50. | Betamethasone Valerate Ointment IP 0.1% w/w | B75 | Aug-24 | Jul-26 | M/s.Syndicate Pharma, 185/B, 185/B-1, 187/A & 188 Sector – F, Sanwer Road, Indore-452015. | Sample does not conform to IP specification for Betamethasone Valerate Ointment with respect to the content of Betamethasone in Betamethasone Valerate | Drugs Testing Laboratory, Madurai-19 |
| 51. | Betamethasone Valerate Cream IP | E4062 | Feb-24 | Jan-26 | M/s.Rhydburg Pharmaceuticals Ltd, C2&3, S.I.E.L, Selaqui, Dehradun, Uttarakhand (India) | Sample does not conform to IP specification for Betamethasone Valerate Cream with respect to the content of Betamethasone in Betamethasone Valerate. | Drugs Testing Laboratory, Madurai-19 |
| 52. | Synclov-625 Tablets (Amoxycillin & Potassium Clavulanate Tablets IP) | MICTAB-2120 | Jan-25 | Jun-26 | M/s.Micro Formulations, Chambaghat, New Railway Crossing, Distt, solan (HP),173211 | Sample does not conform to IP specification for Amoxycillin and Potassium Clavulanate Tablets with respect to Dissolution for Clavulanic Acid and to the content of Clavulanic Acid in Potassium Clavulanate Diluted | Drugs Testing Laboratory, Chennai-06 |
| 53. | Frusemide Injection IP- 2ml | 24BTC63 | Mar-24 | Feb-26 | M/s.SVP Life Sciences, C/10-1, Sara Industrial Estate, Selequi, Dehradun. | Sample does not conform to requirement for sterility | King Institute of Preventive Medicine & Research, Guindy, Chennai-32 |
| 54. | Progaba Gel (Lidocaine Hydrochloride & Gabapentin Gel) | PSWAB66 | Jun-24 | Nov-25 | M/s.Pure & Cure Healthcare Pvt Ltd,(A Subsidiary of Akums Drugs & Pharmaceuticals Ltd) Plot No. 26A, 27-30,Sector-8A, I.I.E, SIDCUL, Haridwar-249 403, Uttarakhand | Sample does not conform to Label claim with respect to the content of Gabapentin | Drugs Testing Laboratory, Madurai-19 |
| 55. | Povigin (Povidone Iodine Ointment USP 5%w/w) | PZ-2414 | Sep-24 | Aug-26 | M/s. GP Glister Pharmaceutical, B-17, AKVN Industrial Area, Rangawasa, RAU, 453331 | Sample does not conform to USP specification for Povidone- Iodine Ointment with respect to the content of Available Iodine in Povidone- Iodine | Drugs Testing Laboratory, Chennai-06 |
| 56. | Pantozor Tablets (Pantoprazole Sodium Tablets IP) | UTBO25A | Feb-25 | Jan-27 | M/s.Haustus Biotech Pvt Ltd, 44- 45, Indl. Area, Tahliwal, Distt, Una (H.P) | Sample does not conform to IP specification for Pantoprazole Tablets with respect to Dissolution in Buffer stage | Drugs Testing Laboratory, Chennai-06 |
| 57. | Frusemide Tablets IP 40mg | TA24283 | Jul-24 | Jun-26 | M/s.Saintlife Pharmaceuticals Ltd, 323, Central Hope Town, Industrial Area, Selaqui, Dehradun-248011, Uttarakhand, India. | Sample does not conform to IP specification for Frusemide Tablets with respect to Dissolution | Drugs Testing Laboratory, Chennai-06 |
| 58. | Atorvastatin Tablets IP 10mg | CT240246A | Jul-24 | Jun-26 | M/s.Candour Pharmaceuticals, Vill. OGLI, Suketi Road, Kala Amb, Distt. Sirmour (H.P), 173030 | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to Dissolution | Drugs Testing Laboratory, Chennai-06 |
| 59. | Diclofenac Sodium Tablets IP | THB24028AL | Jul-24 | Jun-26 | M/s. Hindustan Laboratories Limited, Plot No. 5-9, Survey No.382, Aliyali, Palghar (W), Dist. Palghat 401404 (M.S) | Sample does not conform to IP specification for Enteric Coated Tablets with respect to Disintegration | Drugs Testing Laboratory, Chennai-06 |
| 60. | Atorvastatin Tablets IP 10mg | AT24045 | Aug-24 | Jan-26 | M/s. Eurokem Laboratories Pvt ltd, C-25, SIDCO Pharmaceutical Complex, Alathur, Thiruporur, 603110. | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to Dissolution | Drugs Testing Laboratory, Chennai-06. |
| 61. | Glypro 1 (Glimepiride Tablets IP) 1mg | FGYO-1626 | Dec-24 | Nov-26 | M/s.Firstmed Therapeutics Pvt Ltd, R.S.No.31/1, Pondy- Tindivanam Main Road, Auroville (PO), Thiruchitrambalam, Tamilnadu-605101 | Sample does not conform to IP specification for Glimepiride Tablets with respect to the content of Glimepiride | Drugs Testing Laboratory, Madurai-19 |
| 62. | Merocet (Cetirizine Hydrochloride Syrup) | 1124192 | Nov-24 | Oct-26 | M/s.Kite Formulation, No.67/1, 1st & 2st floor, 4th street, Thirunagar, Karumandapam, Trichy-620001 | Sample does not conform to IP specification with respect to the PH. | Drugs Testing Laboratory, Madurai-19 |
| 63. | Mupropet (Mupirocin Ointment IP 2%w/w) | DG2436 | Jul-24 | Dec-25 | M/s.Arius Formulations Pvt Ltd, R.S.No.141/1, Plot No.38 & 47, Ground Floor, Navarkulam Main Road, Pattanur, Auroville (Post), Vanur taluk, Tamilnadu, 605101 | Sample does not conform to IP specification for Mupirocin Ointment with respect to the content of Mupirocin | Drugs Testing Laboratory, Chennai-06. |
| 64. | Atorvastatin Tablets IP 10mg | A297 | Jul-24 | Jun-26 | M/s.Rikenbik Pharma, 113, SIDCO Industrial Estate, Ambattur, Chennai, 600098 | Sample does not conform to IP specification for Atorvastatin Calcium Tablets with respect to Dissolution | Drugs Testing Laboratory, Chennai-06. |
| 65. | Labetalol Hydrochloride Tablets IP 100 mg | UGT231341 | 10/2023 | Sep-25 | M/s Unimarck Healthcare Ltd., Plot No. 24,25 & 37 Sector 6A, SIDCUL, Haridwar-249403 (Uttarakhand) | Test For Assay(Content) of Labetalol Hydrochloride | Government of NCT of Delhi |
| 66. | Aspirin Gastro Resistant Tab IP 75 mg | ANET1235 | May-24 | Apr-26 | M/s. Unicure India Ltd, C- 21,22&23, sector-3, Noida- 201301, Distt.Guatam Budh Nagar (UP) | It fails the test ‘Dissolution’ Specified in the laboratory protocol as per IP | Drugs Testing Laboratory Thiruvananthapura m |
| 67. | Telmisartan & Amlodipine Tablets IP | UGT24G06A | Oct-24 | Sep-26 | M/s.Unigrow Pharmaceuticals, Vill. Katha, Baddi, Dist. Solan (HP) | It fails the tests for ‘Assay’ of Amlodipine and ‘Dissolution’ as specified in the Laboratory Protocol as per IP | Drugs Testing Laboratory Thiruvananthapura m |
| 68. | Ahaglow Face Wash Gel 50 gm | AHA202 | May-24 | Apr-26 | M/s.Torrent Pharmaceuticals Ltd, Plot No. 810, Sector III, Industrial Area, Pithampur, Dist.Dhar, MP- 454775 | The sample does not conform to Cosmetics Rules 2020 for the standards of cosmetics. It fails the test for the content of ‘Mercury’ in finished cosmetic products as specified in the Laboratory Protocol. | Drugs Testing Laboratory Thiruvananthapura m |
| 69. | Alograce Cream (Vitamin E, Honey & Aloevera Cream) | A2JJX048 | Dec-24 | Dec-26 | M/s.RSH Global Pvt. Ltd, Plot No.3 C, Industrial Area, Baddi- 173 205 | The sample does not conform to IS 6608:2004 for specifications of skin cream. It fails the test for “Heavy metals (as lead) ppm” as specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 70. | Pantonis-40 (Pantoprazole Sodium Gastro Resistant Tab IP) | JMT-2407371 | Jul-24 | Jun-26 | M/s. JMM Laboratories, Vill- Khari,Kala amb, Tehsil, Nahan Sirmour- 173030 | It fails the test ‘Dissolution’ as per IP, as Specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 71. | Nebivolol Tablets IP | KMNB 24002 | Oct-24 | Sep-26 | M/s.Ravian Life Sciences Pvt Ltd, Plot No. 34, sector-8A, IIE, SIDCUL, Haridwar- 249 403, Uttarakhand | It fails the test for ‘Dissolution’ as per IP, as Specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 72. | Mamaearth Vitamin C daily glow light moisturising cream | AM4J160 | Oct-24 | Use before 24 Months from the date Mfg. | M/s.VA Life sciences, LLP, Plot NO. 9D, sector-2, Parvanoo, HP – 173 220 | The sample does not conform to Cosmetics Rules 2020 for the standards of cosmetics. It fails the test for the content of ‘Mercury’ in finished cosmetic products as specified in the Laboratoty Protocol. | Drugs Testing Laboratory Thiruvananthapura m |
| 73. | Ondansetron Tablets IP 4 mg | ONTB-06 | Sep-24 | Aug-26 | M/s.Nestor Pharmaceuticals Limited, 11, Western Extension Area, Faridabad -121 001 | It fails the test for ‘Dissolution’ as per IP as Specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 74. | Paracetamol Tablets IP 500 mg | PAK-517 | May-23 | Apr-26 | M/s. Healer’s Lab Unit II, Plot No. 33, HPSIDC, Extn, Baddi, Dist.Solan HP | It fails the test for ‘Dissolution’ as per IP as Specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 75. | Restomol 650 (Paracetamol Tablets IP 650 mg) | K1224079 | Dec-24 | Nov-27 | M/s.Kaushik Therapeutics (P) Ltd, Plot No.6 &7 , Door No. 728, Kakkanji Cross Street, Paraniputhur Road, Gerugambakkam, Chennai – 600128 | It fails the test for ‘Dissolution’ as per IP as Specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 76. | Nicocred-10 (Nicorandil Tablets 10 mg) | SGT- 241195 | Aug-24 | Jul-26 | M/s.SB Life Sciences Pvt Ltd, At Plot No. 45, EPIP, Phase-I, Jharmajri, Baddi, Distt , Solan (HP) | It fails the tests ‘Dissolution’ and ‘Assay’ as per IP , specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapuram |
| 77. | Cefixime Oral Suspension IP Dry Syrup 30 ml | CADB- 02 | Jun-24 | May-26 | M/s.Nestor Pharmaceuticals Limited, 11, Western Extension Area, Faridabad -121 001 | It fails the test Assay, water and descriptive part for oral liquids as per IP , as specified in the Laboratory Protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 78. | Paracetamol Tab IP 500 mg | PAK-558 | Sep-23 | Aug-26 | M/s.Healer’s Lab Unit II, Plot No. 33, HPSIDC, Extn, Baddi, Dist.Solan HP | It fails the test ‘Dissolution’ as per IP , as Specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 79. | Paracetamol Tab IP 500 mg | PAK-524 | May-23 | Apr-26 | M/s.Healer’s Lab Unit II, Plot No. 33, HPSIDC, Extn, Baddi, Dist.Solan HP | It fails the test ‘Dissolution’ as per IP specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 80. | Tab Telmisartan IP 40 mg | GTM18 | Jun-24 | May-26 | M/s.Super Formulation Pvt Ltd, 16-B, 15-F, Industrial Area , Maxi Road, Ujjain (MP) 456010 | It fails the test ‘Dissolution’ as per IP, specified in the laboratory protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 81. | Telmisartan Tab IP 40 mg | D0004/25-26 | NIL | NIL | M/s.Kerala Medical services Corporation Limited, Thycaud P.O, Thiruvananthapuram | The sample does not conform to IP standards with respect to descriptive part for tablets | Drugs Testing Laboratory Thiruvananthapura m |
| 82. | Paracetamol Tab IP 500 mg | D 0001/25-26 | NIL | NIL | M/s.Kerala Medical services Corporation Limited, Thycaud P.O, Thiruvananthapuram | It fails the tests dissolution as per IP specified in the Laboratory Protocol | Drugs Testing Laboratory Thiruvananthapura m |
| 83. | Gentamicin Inj. IP | D0003/25-26 | NIL | NIL | M/s.Kerala Medical services Corporation Limited, Thycaud P.O, Thiruvananthapuram | It fails the test particulate matter and descriptive part for injections | Drugs Testing Laboratory Thiruvananthapura m |
| 84. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25019 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 29.69 mg per bolus (74.225%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 85. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25018 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Oxfendazole found to be 883.42 mg per bolus (88.342%) against labelled claim of 1000 mg per bolus. | State Drugs Laboratory, Punjab |
| 86. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25038 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | 1. Description. 2. The Content of Ivermectin found to be 34.73 mg per bolus (86.825%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 87. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25025 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 28.57 mg per bolus (71.425%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 88. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25034 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 34.91 mg per bolus (87.275%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 89. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25033 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 26.66 mg per bolus (66.65%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 90. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25032 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 30.19 mg per bolus (75.475%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 91. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25031 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | 1. The content of Ivermectin found to be 32.52 mg per bolus (81.30%) against labelled claim of 40 mg per bolus.2. The Content of Oxfendazole found to be 880.01 mg per bolus (88.001%) against labelled claim of 1000 mg per bolus. | State Drugs Laboratory, Punjab |
| 92. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25037 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | 1. The content of Oxfendazole found to be 877.69 mg per bolus (87.769%) against labelled claim of 1000 mg per bolus. 2. The Content of Ivermectin found to be 28.220 mg per bolus (70.55%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 93. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25041 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 33.19 mg per bolus (82.975%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 94. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25035 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 25.17 mg per bolus (62.925%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 95. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25036 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 28.66 mg per bolus (71.65%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 96. | Aceclofenac & Paracetamol Tablets IP | GG204014 | Apr-24 | Mar-26 | M/s.Innova Captab Limited, 1281/1, Hilltop Industrial Estate, Near EPIP, Phase-1, Jharmajri, Baddi, Distt. Solan (H.P.)-173205 | Misbranded Product is not official in I.P as on its manufacturing date mentioned on its label i.e. April 2024. | State Drugs Laboratory, Punjab |
| 97. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25024 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 33.069 mg per bolus (82.672%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 98. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25029 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 33.29 mg per bolus (83.225%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 99. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25028 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 31.82 mg per bolus (79.55%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 100. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25027 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 31.68 mg per bolus (79.20%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 101. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25026 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 33.055 mg per bolus (82.637%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 102. | Oxfendazole & Ivermectin Bolus (Vet.) WELLMOX-1 | AGWT25030 | Jan-25 | Dec-26 | M/s.Argon Remedies Pvt. Ltd., Sarverkhera. Moradabad Road, Kashipur, U S Nagar, Uttarakhand-244713 | The content of Ivermectin found to be 31.66 mg per bolus (79.15%) against labelled claim of 40 mg per bolus. | State Drugs Laboratory, Punjab |
| 103. | Clonazepam and Paroxetine Hydrochloride CR Tablets (Exotine CR) | 17671 | Feb-24 | Jan-27 | M/s. Elikem Pharmaceuticals Pvt. Ltd., 816/1, Rakanpur, Ta. Kalol, Distt. Gandhinagar, Guj. 382721 | Uniformity of Weight | State Drugs Laboratory, Punjab |
| 104. | Losartan Potassium 50mg & Hydrochlorthiazide 12.5mg Tablets | LMT251666 | Feb-25 | Jan-27 | M/s. Life Max Cancer Laboratories, Plot No: 106 & 106 A, Sector- 6A, IIE, SIDCUL, Haridwar-249403 (U.K) | Dissolution Test: The Dissolution of Losartan Potassium and Hydrochlorthiazide does not complies within the Prescribed limit of not less than Q value i.e. 70% of labelled claim as stated in I.P 2022. | State Drugs Laboratory, Punjab |
| 105. | Calcium & Vitamin D3 Tablets IP (JKMSCL, Supply) | PGT24673 | Sep-24 | Aug-26 | M/s. Affy Parenterals Vill Gullawala P.O. Baddi Distt Solan- 173205 | The sample does not conform to IP 2022 w.r.t Disintegration test for the sample portion received | CDSCO Zone III Jammu |
| 106. | Defix -AZ | DP-240754 | Sep-24 | Aug-26 | M/s. Park Pharmaceuticals 272, Ind. Area, Phase-II, Panchkula 134113 | The sample fails in the test for Assay content of Cefixime & Azithromycin. | CDSCO Zone III, Srinagar |
| 107. | Proxtl 100 DT | PXT123F02 | Mar-23 | May-25 | M/s. INDU Drugs Pvt Ltd.5-5- 35/278,279 & 281/1 (Part) Prasanthi Nagar ida, Kutkapally, Hyderabad-500072 | The sample does not comply with IP requirements for Dissolution test. | FDA Lab, Mumbai- 51 |
| 108. | Telivi-H 40 (Telmisartan & Hydrochorothiazide Tablets IP | BLT23348 | Jun-23 | May-25 | M/s. BRIT Lifescience a GMP Certified Company) Sainwala kaula Wata, Bhood Road, kala AMB Distt. Sirmmour (HP) 173030 | 1. The content of Telmisartan and Hydrochlorothiazide in the sample is less (i.e. 83.13% and 79.44%of the labelled amount respectively) than I.P. limits. 2. The sample does not comply with I.P. Requirements for “Dissolution Test” for Telemisartan and Hydrochlorothiazide. | FDA Lab, Mumbai- 51 |
| 109. | Koplyco Syrup | TL-6337 | Jun-23 | May-23 | M/s. Ticoma Pharmacia E-17 Industrial Focal Point Debrabassi, Derabassi, | 1. Content of vitamin B1 in the sample is less (i.e. 71.10% of the labelled amount) than the permissible limits. 2. Content of the Vitamin B2 in the sample is less (i.e. 72.74%) of the labelled amount) than the permissible limits. | FDA Lab, Mumbai- 51 |
| 110. | Ondansentron Tablets IP 4mg | PS39AB06 | Jun-23 | May-25 | M/s. Pure & Cure Healthcare Pvt Ltd, Plot No. 26A, 27-30, Sector- 8A, LLE. SIDCUL Haridwar, Uttarakhand-249403 | The sample does not comply with IP requirements for Dissolution test | FDA Lab, Mumbai- 51 |
| 111. | Opivas 10 tablets | 23C-T465 | Jun-23 | May-25 | M/s. Orison Pharma International Khari, Mauza-Ogli, Kala AMB- 173030, HP | The sample does not comply with IP requirements for Dissolution test. | FDA Lab, Mumbai- 51 |
| 112. | Cetquine 5 Tablets (Levocetirizine Dihydrochlorine Tablets IP | ATX060546 | Jun-23 | May-25 | M/s. ADWIN Pharma Vill Rampur, Jattan, Trilokpur Road, Kala, Tehsil nahan Sirmour-173030 | The sample does not comply with IP requirements for Dissolution test. | FDA Lab, Mumbai- 51 |
| 113. | ITRADEL-200k | SD6005C | Jun-23 | May-25 | M/s. Sigma Softgel & Formulation plot no. 171, HPSIDC, Industrial Area, B. Dist. Solan HP Baddi- 173202 | The sample does not comply with IP requirements for Dissolution test | FDA Lab, Mumbai- 51 |
| 114. | Phytorab-DSR Capsules | GC 41481 | Jun-23 | May-25 | M/s. J.M. Laboratories Village Bhanat, Po-ghatti, Subathu Road, Solan (HP), Solan 173211 | The content of rabeprazole sodium in the sample is less (i.e. 55.00% of the labelled amount) than the permissible limits | FDA Lab, Mumbai- 51 |
| 115. | Neem tulsi face wash | APN612 | Aug-24 | Aug-26 | M/s. Orgello Herbal Care Vill. Behrewala, Pantoba Sahib Distt. Sirmour (H.P) 173025 | The sample does not comply with IS 14648: 2011 (Second Revision) Reaffirmed 2021 Requirements for Microbiological Examination test for Neem Tulsi Face wash | FDA Lab, Mumbai- 51 |
| 116. | Adivasi Herbal Shampoo | MASH-23-101 | Jan-24 | Dec-26 | M/s. Beauty Birds Cosmetics Bhatti Compound , 1/B Paik 1/1, Plot -112TP-1, Ahmedabad Gujarat 380022 Ahmedabad- 380022 | The sample does not comply with IS 7884:2004 specification for shampoo (Third Revision) reaffirmed 2019 requirements for microbial limit | FDA Lab, Mumbai- 51 |
| 117. | Kivoral Forte(Trypsin and Chymotrypsin Tablets) | SB-4242 | Jul-23 | Jun-25 | M/s. Sano-Cito Thereapeutics Inc Vill Loharan, PO. Ghattii, Solan- 173211 | The enzymatic activity of trypsin chymotrypsin in the sample is less (i.e. 40.52%) of the labelled amount) than the permissible limits. | FDA Lab, Mumbai- 51 |
| 118. | Polergy (Levocetizine Tablets IP 5mg) | 43037 | Jul-23 | Jun-25 | M/.s Ronak Life care Pvt Ltd., R.S. No. 41, At and Post Rajpur, Dist. Patan 384265 | All tablets received for analysis shows light brown coloured spots all over the surface of the tablets when observed in normal daylight with unaided eyes. | FDA Lab, Mumbai- 51 |
| 119. | Glycical-B12 Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension | QL0606 | Jun-24 | May-26 | M/s. Quest laboratories Pvt Ltd. Plot Nol 45, Sector III, Dist. Dhar (MP) Pitampur-454775 | All observations are done in Normal day light conditions with unaided eyes.18 ×200 ml intact brown coloured plastic bottles received for analysis. Out of these18 ×200 ml bottles, in 14 ×200 ml bottles particles are stick around the neck of the bottle and cakes are distributed in the suspension and some cakes are floating on the top of the suspension. During Analysis when the content from these 14×200 ml bottles after shaking transferred individually in clean dry glass beaker, it is observed that, out of these14 × 200ml bottles, 11x200ml bottles contains white suspension with white, pale yellow, grey and black coloured cakes with some cakes floating on the top of suspension and 3x200ml bottle contain orange coloured suspension with white cakes with some cakes floating & on the top of suspension. Remaining 4x200ml bottle contains white suspension without cake and mix uniformly after shaking | FDA Lab, Mumbai- 51 |
| 120. | Glycical-B12 Calcium Phosphate, Vitamin D3 and Vitamin B12 Suspension | QL0602 | Jun-24 | May-26 | M/s. Quest laboratories Pvt Ltd. Plot Nol 45, Sector III, Dist. Dhar (MP) Pitampur-454775 | All observations are done in Normal day light conditions with unaided eyes.18 ×200 ml intact brown coloured plastic bottles received for analysis. Out of these18 ×200 ml bottles, in 5 ×200 ml bottles particles are stick around the neck of the bottle and cakes are distributed in the suspension and some cakes are floating on the top of the suspension. During Analysis when the content from these 5×200 ml bottles after shaking transferred individually in clean dry glass beaker, it is observed that, all 5×200ml bottles, contains white suspension with white, pale yellow, grey and black coloured cakes with some cakes floating on the top of suspension out of remaining 13x200ml bottle 12×200ml bottle contains white suspension without cake and mixes uniformly after shaking and 1×200ml bottles contains orange coloured suspension without any cake and mix uniformly after shaking | FDA Lab, Mumbai- 51 |
| 121. | Fevimed (Paracetamol tablets IP 500 mg) | 451AA05 | Dec-23 | Nov-25 | M/s. Sarv Pharmaceuticals Plot No. 28, Sector-3A,I.I.E. Sidcul Haridwar-2494032 | The Sample does not comply for description as the tablets shows light brown coloured spots on the surface of almost all the tablets | FDA Lab, Chhatrapati Sambhajinagar, Maharashtra |
| 122. | Ronnin 500mg Tablets (Azithromycin Tablets IP 500mg) | PPTC082 | Nov-23 | Oct-26 | M/s. Pratima Pharmaceuticals G.No. 56/3, Pratima Nagar, Pune- Nagar Road, Shikrapur, Pune- 412208 | The sample does not give IP identification test for the presence of Azithromycin. The sample is declared as spurious vide section 17-B(d) of the Drugs and Cosmetics Act, 1940 and Rules, 1945 thereunder | FDA Lab, Chhatrapati Sambhajinagar, Maharashtra |
| 123. | Parasev 500 Tablets(Paracetamol Tablets IP 500mg) | CHT23725 | Mar-24 | Feb-26 | M/s. Cureza Healthcare Pvt Ltd. A.B Road, Girwal , Gwalior- 474001 | The tablets does not comply for description as, the tablets shows uneven light brown coloured spots on the surface of almost all the tablets. | FDA Lab, Chhatrapati Sambhajinagar, Maharashtra |
| 124. | Opirin-75 Tablets (Aspirin Tablets IP 75mg) | 23K-T2727 | Feb-24 | Jan-26 | M/s. Orison Pharma International Khari, Mauza-Ogli, Kala AMB- 173030, HP | The sample does not comply for description as, the tablets shows uneven light brown coloured spots on the surface of almost all the tablets. | FDA Lab, Chhatrapati Sambhajinagar, Maharashtra |
| 125. | Opirin-75 Tablets (Aspirin Tablets IP 75mg) | 23G-T1526 | Oct-23 | Sep-25 | M/s. Orison Pharma International Khari, Mauza-Ogli, Kala AMB- 173030, HP | The sample does not comply for description as, almost all the tablets are brittle in nature with rough surface. | FDA Lab, Chhatrapati Sambhajinagar, Maharashtra |
| 126. | Paracetamol Tablets IP (Pacel-650) | RPTC-182 | Jan-25 | Dec-27 | M/s. Chennai Oscar Bio Pharmaceuticals Pvt. Ltd., 3/558, Kaveri Nagar, Pattu Mangadu, Chennai-600 122 | Does not comply with respect to test for Dissolution. | State lab, Puducherry |
| 127. | Griseofulvin Tablets IP(GRISOVIK-250) | 8563 | May-24 | Apr-26 | M/s.Vikram Laboratories (P) Ltd., Behind tubewell colony, Meerut Road, Muzaffar Nagar- 251 002 (UP) | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform with respect to the test for Description. | State lab, Puducherry |
| 128. | Bisacodyl Gastro- Resistant Tablets IP (Edilax) | 2418853T003 | Jun-24 | May-27 | M/s.Scott-Edil Pharmacia Ltd., Unit-II, Plot No.21-22, E.P.I.P., Phase -I, Jharmajri, Baddi, Distt. Solan – 173 205 (HP) , India. | Does not comply with respect to test for Disintegration | State lab, Puducherry |
| 129. | Aceclofenac & Paracetamol Tablets (Aceflam P) | T-2403035 | Mar-24 | Feb-27 | M/s. Aagya Biotech Pvt Ltd., 1.5km, Manglour,Saharanpur Road,Manglour-247 656, Roorkee, Distt. Haridwar (UK) | On visual inspection, presence of spot was observed on tablets surface. The sample received does not conform as per IP 2022 with respect to Description. | State lab, Puducherry |
| 130. | Cresol With Soap Solution (SPARK) (LYSOL IP) | J-Ly-213 | Mar-25 | Feb-27 | M/s. Joe’s Traders, Plot No, 23 R.S. No: 258/5D, Manaveli Road, Puthurai, Viluppuram, Tamil Nadu-605111 | The sample received does not conform to above specification as per IP 2022 with respect to description. | State lab, Puducherry |
| 131. | Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP(Moncube LC) | FDMC-588 | Jul-24 | Jun-26 | M/s. Firstmed Therapeutics Pvt Ltd., R.S. No.31/1,Pondy- Tindivanam Main Road,Auroville (PO),Thiruchitrambalam,Tamilnad u-605 101 | For the received sample Montelukast Sodium & Levocetirizine Hydrochloride Tablets IP (Moncube LC) ,Presence of Spots was observed which should not be present | State lab, Puducherry |
| 132. | Glimepiride Tablets (Glimilive – 4) | MDP-649 | Sep-24 | Aug-26 | M/s. Medinok healthcare Pvt. Ltd., R.S.No. 2/1, Plot No. 87, 88, 89, Vazhudhavur Main Road, Kurumbapet, Puducherry – 605 009. | Misbranded For the received sample Glimepiride Tablets (Glimilive – 4) , The label is mentioned as ‘Approved colour used’ but common name of the permitted colour used in the formulation as prescribed under rule 127(2) of the Drugs Rules ,1945 was not mentioned.The sample received is labelled as Glimepiride Tablets (Glimilive – 4) , however Glimepiride Tablets is an official IP monograph (2022) hence should be labelled as Glimepiride Tablets IP | State lab, Puducherry |
| 133. | Aceclofenac With Paracetamol Tablets (S-DOL-P) | MDP-018 | Apr-24 | Mar-26 | M/s. Medinok Healthcare Pvt Ltd, R.S. No: 2/1, Plot No: 87,88,89, Vazhudhavur Main Road, Kurumbapet, Puducherry- 605009 | Misbranded The label of the container in the drug is mentioned as “Approved colour used” but the common name of the permitted colour used in the formulation as prescribed under rule 127 (2) of the drug rule was not mentioned. | State lab, Puducherry |
| 134. | Paracetamol, Phenylephrine HCL & Cetrizine HCL Suspension | OKOL-009 | Jul-24 | Jun-26 | M/s. Laborate Pharmaceuticals India Ltd. (Unit0II) #31, Rajban road, Nariwala Poanta Sahib H.P. | The sample does not conform to claim as per Patent and Proprietary in respect of the assay of Phenylephrine Hydrochloride. | DTL Baddi |
| 135. | Ibuprofen Tablets IP 400mg | TF240782 | Jun-24 | Aug-26 | M/s. Orchid Medlife Pvt. Ltd., K.H- 646/513, Vill. Kaumdi, Thana, Baddi, distt. Solan HP | Sample does not conform to claim as per I.P. 2022 w.r.t. Dissolution of Ibuprofen. | DTL Baddi |
| 136. | Telmisartan & Amlodipine Tablets IP (XTEL-AM) | BBT240427A | May-24 | Apr-26 | M/s. Biomax Biotechnics (P) Ltd 261,HSIIDC, Industrial Estate Alipur, Barwala-134118 Haryana | The sample does not conform to the claim as per IP 2022 in respect to Dissolution Test of Amlodipine | DTL Baddi |
Not of Standard Quality (NSQ) drugs:
The drugs that fail to meet the quality standards or specifications are known as Not of Standard Quality (NSQ) drugs.
(Further, the term ‘standards of quality’ is defined under the Section 16 (1) (a) of Drugs & Cosmetics Act, 1940, that the ‘standards of quality’ mean that the drug complies with the standards set out in the Second Schedule of the said Act.)
NOTE:
1. NSQ data received from State Drugs Licensing Authorities of Assam 03 (02 NSQ already listed in CDSCO alert in the month of March-2025 and 01 listed in the CDSCO alert in the month of April-2025), Goa (Nil), Himachal Pradesh 08 (03 NSQ already listed in CDSCO alert in the month of March-2025 and 02 listed in the CDSCO alert in the month of April-2025), Jharkhand 20 (All are listed in the CDSCO alert in the month of April-2025), Karnataka, Kerala, Maharashtra, Punjab, Tamil Nadu, Telangana, Tripura , West Bengal (Nil) , Puducherry, NCT, Delhi, Jammu & Kashmir, for the month of April, 2025 as per DCG (I) Circular dated 09.02.2024.
2. State Drugs Licensing Authorities of Andhra Pradesh, Arunachal Pradesh, Bihar, Chhattisgarh, Gujarat, Haryana, Madhya Pradesh, Manipur, Meghalaya, Mizoram, Nagaland, Odisha, Rajasthan, Sikkim, Uttar Pradesh, Uttarakhand, , Andaman & Nicobar Islands, Chandīgarh, Dadar and Nagar Haveli, Daman and Diu, Lakshadweep, Ladakh, have not submitted any data in respect of the Not of Standard Quality (NSQ) Alert for the Month of April, 2025 as per DCG(I) Circular dated 09.02.2024.
